Evidence map›Paper›PMID 14509568›Full record

ReviewCerebellum (London, England)2003

Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Kurt F Hauser, Valeriya K Khurdayan, Robin J Goody, Avindra Nath, Alois Saria, James R Pauly

Open access · greenAbstract readReview
In one paragraph

Review in Cerebellum (London, England), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Allosteric modulation of α1β3γ2 GABABiophysical journal · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Reversal of neuronal migration in a mouse model of fetal alcohol syndrome by controlling second-messenger signalings.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kurt F HauserDepartment of Anatomy & Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky, 40536-0298, USA. khauser@uky.edu
Valeriya K Khurdayan
Robin J Goody
Avindra Nath
Alois Saria
James R Pauly
University of Kentucky · US

Funding

ROLE OF ABUSED OPIATE DRUGS IN NEURAL DEVELOPMENTR01DA006204 · NIDA · UNIVERSITY OF KENTUCKY · PI HAUSER, KURT FRANCIS · 1990 to 2000
$163k
EFFECTS OF PRENATAL NICOTINE EXPOSURE ON BRAIN N-ACHRR29DA008443 · NIDA · UNIVERSITY OF KENTUCKY · PI PAULY, JAMES R · 1993 to 1997
–
NIDA NIH HHS DA 06204NIDA NIH HHS DA 08443NIDA NIH HHS R01 DA006204
6 · The paper itself

Abstract

Cerebellar development is shaped by the interplay of genetic and numerous environmental factors. Recent evidence suggests that cerebellar maturation is acutely sensitive to substances with abuse liability including alcohol, opioids, and nicotine. Assuming substance abuse disrupts cerebellar maturation, a central question is: what are the basic mechanisms underlying potential drug-induced developmental defects? Evidence reviewed herein suggests that the maturation of granule neurons and their progeny are intrinsically affected by several classes of substances with abuse liability. Although drug abuse is also likely to target directly other cerebellar neuron and glial types, such as Purkinje cells and Bergmann glia, findings in isolated granule neurons suggest that they are often the principle target for drug actions. Developmental events that are selectively disrupted by drug abuse in granule neurons and/or their neuroblast precursors include proliferation, migration, differentiation (including neurite elaboration and synapse formation), and programmed cell death. Moreover, different classes of drugs act through distinct molecular mechanisms thereby disrupting unique aspects of development. For example, drug-induced perturbations in: (i) neurotransmitter biogenesis; (ii) ligand and ion-gated receptor function and their coupling to intracellular effectors; (iii) neurotrophic factor biogenesis and signaling; and (iv) intercellular adhesion are all likely to have significant effects in shaping developmental outcome. In addition to identifying therapeutic strategies for drug abuse intervention, understanding the mechanisms by which drugs affect cellular maturation is likely to provide a better understanding of the neurochemical events that normally shape central nervous system development.

Indexed as

AlcoholismAnimalsCerebellumHumansNeuronsOpioid-Related DisordersSubstance-Related DisordersTobacco Use Disorder

Identifiers

PMID14509568
PMCPMC4306667
OpenAlexW2060466278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.